Products

Artera (formerly WELL Health)
Artera
Patient Engagement & Education
Artera (formerly WELL Health) provides a unified communication hub for health systems, sitting on top of existing EHR systems to automate workflows, send appointment reminders, and collect patient feedback. The platform aims to deliver the best experience to patients and healthcare staff through seamless, integrated communications, allowing patients to manage healthcare communications from one recognizable phone number and staff to reduce busy work.
ArteraAI Prostate
Artera
Oncology AI
ArteraAI Prostate is an AI-powered diagnostic test that provides prognostic and predictive insights for localized prostate cancer, aiding in personalized treatment decisions and improving patient outcomes.

See all 2 products →

About Artera

ArteraAI is a leading healthcare AI company specializing in precision medicine, developing advanced artificial intelligence-driven predictive and prognostic tests for personalized cancer care. Their multi-modal artificial intelligence (MMAI) platform analyzes digital pathology images and clinical data to provide individualized insights for cancer management. This technology has been validated in numerous large, randomized Phase III clinical trials, demonstrating its efficacy in predicting patient outcomes and therapeutic benefits.

The company’s flagship product, the ArteraAI Prostate Test, is an FDA-cleared, AI-powered digital pathology risk stratification tool regulated as Software as a Medical Device (SaMD). It is designed to offer therapeutic insights in early-stage prostate cancer, predicting which NCCN Intermediate-risk patients will benefit from short-term androgen deprivation therapy (ST-ADT) with their radiation therapy. This test is notable as the first and only AI test to be recommended in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer.

ArteraAI’s mission is to empower clinicians with more confident treatment decisions by providing personalized data, ultimately improving patient outcomes. Beyond prostate cancer, the company is actively expanding its AI capabilities to analyze additional biomarkers, integrate genomic data with imaging analysis, and develop comprehensive diagnostic tools for other cancer types, including breast cancer.

Focus Areas

Patient communication AI-powered virtual agents patient engagement scheduling intake payments EHR integrations multilingual support reducing staff burden improving patient access digital front door care coordination

Business Intelligence

Key InvestorsLead Edge Capital, Jackson Square Ventures, Health Velocity Capital, Heritage Medical Systems, Summation Health Ventures
PartnershipsFederally Qualified Health Centers (FQHCs) including Bedford-Stuyvesant Family Health Center and Moses Lake Community Health Center, Azara Healthcare, Health iPASS, Memora Health, Feedtrail, Hyro, Prisma Health, Gozio, Twilio, Cerner, OSIS
AcquisitionsAudioCARE (2023)
TechnologyAI-powered virtual agents (voice and text), Artera Harmony platform, Agentic AI, cloud-native SaaS, deep integration with EHRs/EMRs (e.g., Oracle Health, MEDITECH), API, FHIR, and HL7v2 protocols, Model Context Protocol (MCP)

What Physicians Need to Know

Patient Communication & Engagement
Artera specializes in conversational, HIPAA-compliant patient communications at scale, facilitating billions of messages annually across 109 languages. They focus on transforming the patient experience, improving access, and driving engagement through personalized, timely messaging.
AI-Powered Virtual Agents
Offers flexible virtual agent solutions (voice and text) including Staff AI Co-pilot, Flows Agents, and fully autonomous AI Agents. These agents handle various tasks such as scheduling, intake, billing, and pre-procedure instructions, adapting to an organization's AI adoption pace.
Scheduling & Intake
Provides comprehensive solutions for self-scheduling, waitlist management, automated scheduling workflows, and digital patient intake and forms to streamline administrative processes and improve patient access.
Payments & Revenue Cycle
Facilitates digital patient payments and helps capture revenue faster through automated intake and billing processes.
EHR & System Integrations
Seamlessly integrates with leading EHRs like Epic, MEDITECH, eClinicalWorks, ModMed, Greenway Health, athenahealth, and Oracle Health, utilizing API, FHIR, and HL7v2 standards. This ensures unified communication across a healthcare organization's tech stack.
Staff Burden Reduction
Artera's solutions are designed to significantly reduce staff time (up to 72% reduction reported) by automating high-volume, repetitive administrative tasks, allowing staff to focus on higher-value patient care.
Digital Front Door & Care Coordination
Artera Harmony acts as an 'air traffic controller' for patient messaging, consolidating communications from multiple digital vendors to prevent message fatigue and provide a unified patient experience. It also supports chronic condition care coordination and follow-up.
Physician Tip

For physicians, Artera stands out by significantly reducing administrative burden through automation of tasks like scheduling, intake, and billing, freeing up staff to focus on patient care. The platform improves patient access and engagement with features like self-scheduling, multilingual support, and streamlined communication, leading to fewer no-shows and better patient follow-through. This translates to enhanced practice efficiency and profitability through increased appointment adherence and recouped revenue. Its seamless integration with existing EHRs ensures consistent data flow and patient journeys, while specialty-specific AI agents address unique challenges across various medical fields. Furthermore, Artera's commitment to HIPAA compliance, HITRUST, and SOC 2 Type 2 certification ensures reliable and secure patient communication, without using PHI/PII for training models. The 'Digital Front Door' orchestration provided by Artera Harmony consolidates communications, preventing patient message overload and fostering a more positive patient experience.

Artera's integration-first philosophy is a key differentiator, offering seamless connectivity with all leading EHRs and digital health vendors via API, FHIR, and HL7v2. This robust integration capability allows for conversational messaging driven by EHR insights, reducing referral leakage, maximizing schedule utilization, and making check-in more accessible. They partner with a wide ecosystem of healthcare vendors to unify and orchestrate digital communications into the patient's preferred channel.

Products by Artera

2 products in the directory

Artera (formerly WELL Health)
Artera
Patient Engagement & Education
Artera (formerly WELL Health) provides a unified communication hub for health systems, sitting on top of existing EHR systems to automate workflows, send appointment reminders, and collect patient feedback. The platform aims to deliver the best experience to patients and healthcare staff through seamless, integrated communications, allowing patients to manage healthcare communications from one recognizable phone number and staff to reduce busy work.
ArteraAI Prostate
Artera
Oncology AI
ArteraAI Prostate is an AI-powered diagnostic test that provides prognostic and predictive insights for localized prostate cancer, aiding in personalized treatment decisions and improving patient outcomes.

What the Web Says

Artera (formerly WELL Health) is a patient communications platform widely praised for its ability to streamline patient engagement, particularly through automated appointment reminders, mass messaging, and two-way communication via text, email, and phone. It aims to reduce staff workload, improve patient satisfaction, and decrease missed appointments. While generally well-received for its product, employer reviews present a mixed picture, with some highlighting good training and benefits, while others point to high employee turnover and a retaliatory culture in some departments.

Overall: Mixed

Strengths

  • Efficient and user-friendly patient communication tools, especially for text messaging.
  • Reduces missed appointments and phone calls, saving staff time.
  • Strong campaign functionality for mass outreach and targeted messaging.
  • Responsive customer service and support.
  • Good integration with existing EHR and other healthcare systems.
  • Offers features like bilingual support and customizable reminders.

Limitations

  • Some users experience messaging issues, particularly with managing multiple team messages and appointment cancellations.
  • Limited features for larger organizations, impacting efficiency with high patient volumes.
  • Difficult navigation for larger organizations with numerous practices.
  • Occasional issues with automated messages not firing as expected.
  • High employee turnover, especially in the Finance department.
  • Some reports of a political and retaliatory company culture.

Based on reviews from: G2, Capterra, Indeed.com, Reddit, FeaturedCustomers, Elion Health, InHerSight

Last updated: 2026-07-20

Videos

News, demos, and interviews about Artera.

Loading videos...

Videos load interactively. If none appear, search YouTube for Artera →

View all on YouTube

Press & Coverage

PR Newswire
Artera Secures $65M Growth Investment and Reaches $100M CARR
Artera announced a $65 million growth investment and achieved $100 million in Contracted Annual Recurring Revenue (CARR) by the end of 2025, aiming to accelerate the adoption of Agentic AI in healthcare. The funding will fuel further growth and the deployment of AI Agents to address patient access challenges.
2025-12
Artera
Artera Announces AI Services Model for Specialty Care, FQHCs and More
Artera unveiled its AI Services Model for Specialty Care, FQHCs, and other healthcare providers, aiming to co-innovate bespoke solutions in direct partnership with healthcare organizations. This model deploys specialized teams to combine AI power with an understanding of unique provider segment challenges.
2026-05
Business Wire
Artera Secures CE Marking for Its AI Prostate and Breast Cancer Assays, Unlocking Global Expansion
Artera was granted CE marking under the EU In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI Prostate Biopsy Assay and ArteraAI Breast Cancer Assay, marking a significant step in the company's global expansion. This allows clinical use of Artera's AI-powered tests across all 27 EU member states and EFTA countries.
2026-04
ArteraAI
Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding Its AI Platform to Breast Cancer
Artera announced U.S. FDA clearance of ArteraAI Breast for use in patients with early-stage, hormone receptor-positive, HER2-negative invasive breast cancer. This is the first and only FDA-cleared digital pathology-based risk stratification tool for breast cancer.
2026-05
ArteraAI
Artera Receives U.S. FDA De Novo Marketing Authorization for AI-Digital Pathology Software Revolutionizing Prostate Cancer Care
Artera received De Novo authorization from the U.S. FDA for ArteraAI Prostate, making it the first and only AI-powered software authorized to prognosticate long-term outcomes for patients with non-metastatic prostate cancer. This establishes a new product code category for future AI-powered digital pathology risk-stratification tools.
2025-08
Business Wire
U.S. FDA Grants Artera Breakthrough Device Designation for AI-Powered Software Transforming Prostate Cancer Care
The U.S. FDA granted Breakthrough Device Designation to ArteraAI Prostate, an AI precision medicine tool to assist clinicians with risk-based decisions for patients with localized prostate cancer. This designation may expedite the FDA authorization process for the software.
2025-07
ArteraAI
Journal of Clinical Oncology Publishes Significant Evidence in Advancing Racial Equity in Cancer Care Through Artera's Multimodal AI Model
The Journal of Clinical Oncology published a validation study on Artera's Multimodal AI (MMAI) model, showing no evidence of algorithmic bias and potentially mitigating racial bias in prostate cancer treatment. This is the first comparative analysis of a large digital pathology AI prognostic model in diverse patient populations.
2025-11
PR Newswire
Artera Achieves FedRAMPu00ae Class D Certification for Artera Harmony Federal Edition
Artera Harmony Federal Edition achieved FedRAMPu00ae Class D Certification, meeting FedRAMP security requirements and receiving an Authority to Operate. This allows Artera to expand its partnerships with federal healthcare agencies.
2026-06

Frequently Asked Questions

Artera provides an AI-powered patient communications platform designed to streamline interactions across the entire patient journey, from scheduling to billing. It aims to enhance patient engagement, reduce staff workload, and improve patient access by unifying communications through secure, bidirectional, and multilingual messaging channels like text, email, IVR, and webchat.
Artera offers scalable AI virtual agents, including Co-Pilot Agents for staff support, Semi-Autonomous Flows Agents for routine tasks, and fully-autonomous AI Agents that act as digital office staff. These agents can automate various workflows such as self-scheduling, intake forms, billing inquiries, appointment reminders, and post-discharge follow-ups, freeing up staff to focus on patient care.
Artera's platform is designed for deep, seamless integration with all leading EHRs and digital health vendors, utilizing API, FHIR, and HL7v2 protocols to streamline data exchange. They integrate with major systems like Epic, MEDITECH, eClinicalWorks, ModMed, Greenway Health, athenahealth, and Oracle Health, enabling unified communication and better care coordination.
Artera is HIPAA compliant and will sign a Business Associate Agreement (BAA) to ensure the protection and processing of Protected Health Information (PHI). The company also holds HITRUST CSF certification, ISO 27001, ISO 27017, and ISO 27701 certifications, demonstrating a robust commitment to security and privacy standards.
Yes, Artera provides multilingual engagement capabilities, supporting communication in over 109 languages. This feature helps healthcare organizations efficiently reach underserved populations and ensures patients can communicate in their preferred language, improving access and understanding.
Artera's pricing is typically based on the specific package of features and solutions best suited for a healthcare system, rather than publicly listed rates. Organizations interested in their services are encouraged to contact Artera directly to obtain current pricing and discuss a tailored solution.
Artera Harmony is a comprehensive patient communications platform that acts as an 'air traffic controller' for patient messaging, integrating disparate digital vendors and departments. It unifies and orchestrates all patient communications into a single, coordinated experience, reducing message overload and improving care coordination across the enterprise.
Artera, founded in 2015, is a well-established company trusted by over 1,000 healthcare organizations, including large IDNs, FQHCs, and federal agencies, supporting billions of patient communications annually. They recently secured a $65 million growth investment, reaching $100 million in Contracted Annual Recurring Revenue (CARR) by the end of 2025, indicating strong financial stability and market presence.

Investors

Who's funded Artera.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.